UPDATE: Cowen Upgrades Endocyte (ECYT) to Outperform Citing 'Very Favorable' Risk/Reward at Current Valuation
(Updated - February 27, 2018 7:36 AM EST)
(updated to add analyst ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(updated to add analyst ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
